Search research articles
Contact Us
Filters
Showing results (21-30 of 259) with videos related to
Page
of 26
Sort By:
Ethnicity & Disease
|
February 24, 2005
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in diabetic nephropathy? ACE inhibitors
Errol D Crook, Sreelatha Penumalee
The New England Journal of Medicine
|
September 30, 1993
Hormone replacement and cardiovascular risk factors
D Crook, J C Stevenson
British Journal of Clinical Practice. Supplement
|
September 1, 1996
Transdermal hormone replacement therapy, serum lipids and lipoproteins
D Crook, J C Stevenson
The American Journal of the Medical Sciences
|
September 21, 2002
Traditional and non-traditional risk factors for cardiovascular and renal disease in African Americans: a project of the Jackson Heart Study investigators
Errol D Crook, Herman Taylor
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
February 14, 2006
Thiazolidinediones and progression of renal disease in patients with diabetes
Abhijeet Goyal, Errol D Crook
Annals of the Rheumatic Diseases
|
October 1, 1977
Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase
D Crook, A J Collins
Current Hypertension Reports
|
May 2, 2003
Are low target blood pressure goals justified in persons with diabetes mellitus?
Errol D Crook, Latha Velusamy
British Journal of Obstetrics and Gynaecology
|
August 1, 1991
Progestogens, lipid metabolism and hormone replacement therapy
D Crook, J C Stevenson
Ethnicity & Disease
|
October 26, 2006
Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease
Errol D Crook, Sejal Patel
Archives of Internal Medicine
|
June 1, 1992
Plague. A clinical review of 27 cases
L D Crook, B Tempest
Page
of 26
Search research articles
Search
Showing results (21-30 of 259) with videos related to
Sort By:
Page
of 26
Ethnicity & Disease
|
February 24, 2005
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in diabetic nephropathy? ACE inhibitors
Errol D Crook, Sreelatha Penumalee
The New England Journal of Medicine
|
September 30, 1993
Hormone replacement and cardiovascular risk factors
D Crook, J C Stevenson
British Journal of Clinical Practice. Supplement
|
September 1, 1996
Transdermal hormone replacement therapy, serum lipids and lipoproteins
D Crook, J C Stevenson
The American Journal of the Medical Sciences
|
September 21, 2002
Traditional and non-traditional risk factors for cardiovascular and renal disease in African Americans: a project of the Jackson Heart Study investigators
Errol D Crook, Herman Taylor
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
February 14, 2006
Thiazolidinediones and progression of renal disease in patients with diabetes
Abhijeet Goyal, Errol D Crook
Annals of the Rheumatic Diseases
|
October 1, 1977
Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase
D Crook, A J Collins
Current Hypertension Reports
|
May 2, 2003
Are low target blood pressure goals justified in persons with diabetes mellitus?
Errol D Crook, Latha Velusamy
British Journal of Obstetrics and Gynaecology
|
August 1, 1991
Progestogens, lipid metabolism and hormone replacement therapy
D Crook, J C Stevenson
Ethnicity & Disease
|
October 26, 2006
Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease
Errol D Crook, Sejal Patel
Archives of Internal Medicine
|
June 1, 1992
Plague. A clinical review of 27 cases
L D Crook, B Tempest
Page
of 26